RxDoctor Payments Data

Alan Epstein

Clinical Pathology · Los Angeles, CANPI 1215174503

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $530,524 of the $530,774 with a category attached, or 100.0%. EMD Millipore Corporation accounts for 100.0% of it on its own, with 2 other manufacturers making up the rest. Among clinical pathology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$530,774in general payments, 2019–2025

Across 72 payments — averaging $7371.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • EMD Millipore Corporation$531K
  • AbbVie$125
  • Dendreon Pharmaceuticals LLC$125

What the payments were for

  • Royalty or licence$530,524100%
  • Food & beverage$2500%

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
EMD Millipore Corporation70$530,524
AbbVie1$125
Dendreon Pharmaceuticals LLC1$125

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$530,774 in reported general payments places this provider in the 95th percentile of 20 clinical pathology providers in California.

See all clinical pathology providers in California →

Other clinical pathology in Los Angeles

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →